InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: drryan post# 2562

Tuesday, 05/17/2016 6:23:22 PM

Tuesday, May 17, 2016 6:23:22 PM

Post# of 233189
Eyes on the prize buddy, the June 20th results is what will get this going. To the point of many saying why the abstract didn't move the stock its because the company couldn't release detailed results.

These results are for the monotherapy portion of the study. That means patients can ditch their ART regimen and only need to stay on Pro 140 to keep viral suppression. This is huge, and I am happy to be a long-term holder here. I am keeping my eye on the prize phase 3 data and possibly FDA approval.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News